CHICAGO, IL USA (UroToday.com) - Presented by Robert B. Montgomery, MD;1 Mario A. Eisenberger, MD;2 Elisabeth I. Heath, MD;3 A. Oliver Sartor, MD;4 Franklin Chu, MD;5 Neal D. Shore, MD;6 William Jeffery Edenfield, MD;7 Alan J. Koletsky, MD;8 David Uri Lipsitz, MD;9 James S. Cochran, MD;10 Luke T. Nordquist, MD;11 Jennifer Roberts;12 and Mary-Ellen Taplin, MD13 at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting - May 30 - June 3, 2014 - Chicago, Illinois USA
Click HERE to listen to an interview with Robert Bruce Montgomery, MD, one of the authors of the study
1University of Washington, Seattle, WA; 2The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; 3Karmanos Cancer Institute, Wayne State University, Detroit, MI; 4Tulane University, New Orleans, LA; 5San Bernadino Urological Associates, San Bernadino, CA; 6Carolina Urologic Research Center, Atlantic Urology Clinics, Myrtle Beach, SC; 7Cancer Centers of the Carolinas, Greenville, SC; 8Center for Hematology-Oncology, Boca Raton, FL; 9Carolina Urology, Concord, NC; 10Urology Clinics of North Texas, Dallas, TX; 11Urology Cancer Center and GU Research Network, LLC, Omaha, NE; 12Tokai Pharmaceuticals, Cambridge, MA; 13Dana–Farber Cancer Institute, Boston, MA
